Report Thumbnail
Product Code LP0913317527Q0
Published Date 2026/8/19
English100 PagesGlobal

Global Accelerator-based BNCT System Market Growth (Status and Outlook) 2026-2032 ‐ MedicalDevice / MedTech Market


Report Thumbnail
Product Code LP0913317527Q0
Published Date 2026/8/19
English 100 PagesGlobal

Global Accelerator-based BNCT System Market Growth (Status and Outlook) 2026-2032 ‐ MedicalDevice / MedTech Market



Abstract

This report provides a comprehensive analysis of the global accelerator-based Boron Neutron Capture Therapy (BNCT) system market, forecasting rapid growth through 2032. Driven by technological advancements in compact neutron sources like cyclotrons and linear accelerators, the market is expanding to address refractory and recurrent cancers. The study examines key segments including equipment, solutions, and drugs, while analyzing applications such as brain tumors and head and neck cancer. Furthermore, it evaluates competitive landscapes, regional trends, and strategic developments among leading industry players.

Related Questions

US$ 380 million in 2025 and US$ 7079 million in 2032

52.9% from 2026 to 2032

Neutron Therapeutics, Sumitomo Heavy Industries, International Particle Therapy Inc (IPT), RaySearch, Neuboron Medtech, TAE Life Sciences, Stella Pharma

Progress in technology for accelerator-based neutron sources, Need for high-intensity neutrons, Development of compact accelerator-based neutron sources


Summary

Market Overview

The global Accelerator-based BNCT System market is projected to grow from US$ 380 million in 2025 to US$ 7079 million in 2032, representing a compound annual growth rate (CAGR) of 52.9% from 2026 to 2032.

Technology and Clinical Context

Recent technological progress in accelerator-based neutron sources has significantly increased attention regarding Boron Neutron Capture Therapy (BNCT). BNCT is a specialized type of radiotherapy that combines neutrons and boron drugs, and it is expected to be utilized in the treatment of refractory and recurrent cancers.

Technical Requirements and Development

Due to the necessity for high-intensity neutrons during treatment, compact accelerator-based neutron sources applicable to BNCT are currently under development worldwide. Key technical aspects include:

  • Accelerator Types: Current projects utilize cyclotrons, linear accelerators, and electrostatic accelerators as the primary accelerators for BNCT devices.
  • Target Materials: Beryllium and lithium serve as the primary target materials for neutron generation.
  • Beam Requirements: Accelerators for BNCT devices must be capable of accelerating charged particles with an average current ranging from a few milliamperes to a few tens of milliamperes to generate neutrons of sufficient intensity for clinical treatment.
  • Target System Challenges: Target systems require advanced technologies and mechanisms capable of withstanding the large heat loads produced by high-power beam irradiation and preventing blistering.

Regional Market Outlook

  • United States: The market for Accelerator-based BNCT Systems is expected to experience significant growth from 2025 through 2032.
  • China: The market for Accelerator-based BNCT Systems is projected to expand steadily between 2025 and 2032.
  • Europe: The market for Accelerator-based BNCT Systems is anticipated to see continuous growth from 2025 to 2032.

Market Segmentation

By Type

  • Equipment
  • Solution
  • Drug

By Application

  • Head and Neck Cancer
  • Brain Tumor
  • Others

By Geography

  • Americas: United States, Canada, Mexico, Brazil
  • APAC: China, Japan, Korea, Southeast Asia, India, Australia
  • Europe: Germany, France, UK, Italy, Russia
  • Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Key Global Players

The global landscape includes several key players, such as:

  • Neutron Therapeutics
  • Sumitomo Heavy Industries
  • International Particle Therapy Inc (IPT)
  • RaySearch
  • Neuboron Medtech
  • TAE Life Sciences
  • Stella Pharma

Market Concentration: In 2025, the two largest companies in the global market are expected to hold a significant portion of the total market share.

About the Report

The “Accelerator-based BNCT System Industry Forecast” by LPI (LP Information) provides a comprehensive analysis of the industry.

Scope and Methodology

  • Historical and Projected Data: The report reviews total global Accelerator-based BNCT System sales in 2025 and provides a comprehensive analysis of projected sales for the period from 2026 through 2032.
  • Detailed Breakdown: Sales are analyzed in US$ millions and broken down by region, market sector, and sub-sector.
  • Strategic Insights: The report highlights key trends related to product segmentation, company formation, revenue, market share, latest developments, and M&A activity.
  • Company Analysis: The study analyzes the strategies of leading global companies, focusing on their Accelerator-based BNCT System portfolios, capabilities, market entry strategies, market positions, and geographic footprints.
  • Market Drivers: The report evaluates key market trends, drivers, and affecting factors shaping the global outlook to identify emerging pockets of opportunity.
  • Methodology: The study utilizes a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs to offer a nuanced view of the current state and future trajectory of the global market.

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Accelerator-based BNCT System Market Size (2021-2032)
      • 2.1.2 Accelerator-based BNCT System Market Size CAGR by Region (2021 VS 2025 VS 2032)
      • 2.1.3 World Current & Future Analysis for Accelerator-based BNCT System by Country/Region (2021, 2025 & 2032)
    • 2.2 Accelerator-based BNCT System Segment by Type
      • 2.2.1 Equipment
      • 2.2.2 Solution
      • 2.2.3 Drug
      • 2.2.4 Accelerator-based BNCT System Market Size by Type
        • 2.2.4.1 Accelerator-based BNCT System Market Size CAGR by Type (2021 VS 2025 VS 2032)
        • 2.2.4.2 Global Accelerator-based BNCT System Market Size Market Share by Type (2021-2026)
    • 2.3 Accelerator-based BNCT System Segment by Application
      • 2.3.1 Head and Neck Cancer
      • 2.3.2 Brain Tumor
      • 2.3.3 Others
      • 2.3.4 Accelerator-based BNCT System Market Size by Application
        • 2.3.4.1 Accelerator-based BNCT System Market Size CAGR by Application (2021 VS 2025 VS 2032)
        • 2.3.4.2 Global Accelerator-based BNCT System Market Size Market Share by Application (2021-2026)
  • 3 Accelerator-based BNCT System Market Size by Player

    • 3.1 Accelerator-based BNCT System Market Size Market Share by Player
      • 3.1.1 Global Accelerator-based BNCT System Revenue by Player (2021-2026)
      • 3.1.2 Global Accelerator-based BNCT System Revenue Market Share by Player (2021-2026)
    • 3.2 Global Accelerator-based BNCT System Key Players Head office and Products Offered
    • 3.3 Market Concentration Rate Analysis
      • 3.3.1 Competition Landscape Analysis
      • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
    • 3.4 New Products and Potential Entrants
    • 3.5 Mergers & Acquisitions, Expansion
  • 4 Accelerator-based BNCT System by Region

    • 4.1 Accelerator-based BNCT System Market Size by Region (2021-2026)
    • 4.2 Global Accelerator-based BNCT System Annual Revenue by Country/Region (2021-2026)
    • 4.3 Americas Accelerator-based BNCT System Market Size Growth (2021-2026)
    • 4.4 APAC Accelerator-based BNCT System Market Size Growth (2021-2026)
    • 4.5 Europe Accelerator-based BNCT System Market Size Growth (2021-2026)
    • 4.6 Middle East & Africa Accelerator-based BNCT System Market Size Growth (2021-2026)
  • 5 Americas

    • 5.1 Americas Accelerator-based BNCT System Market Size by Country (2021-2026)
    • 5.2 Americas Accelerator-based BNCT System Market Size by Type (2021-2026)
    • 5.3 Americas Accelerator-based BNCT System Market Size by Application (2021-2026)
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Accelerator-based BNCT System Market Size by Region (2021-2026)
    • 6.2 APAC Accelerator-based BNCT System Market Size by Type (2021-2026)
    • 6.3 APAC Accelerator-based BNCT System Market Size by Application (2021-2026)
    • 6.4 China
    • 6.5 Japan
    • 6.6 South Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
  • 7 Europe

    • 7.1 Europe Accelerator-based BNCT System Market Size by Country (2021-2026)
    • 7.2 Europe Accelerator-based BNCT System Market Size by Type (2021-2026)
    • 7.3 Europe Accelerator-based BNCT System Market Size by Application (2021-2026)
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Accelerator-based BNCT System by Region (2021-2026)
    • 8.2 Middle East & Africa Accelerator-based BNCT System Market Size by Type (2021-2026)
    • 8.3 Middle East & Africa Accelerator-based BNCT System Market Size by Application (2021-2026)
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Global Accelerator-based BNCT System Market Forecast

    • 10.1 Global Accelerator-based BNCT System Forecast by Region (2027-2032)
      • 10.1.1 Global Accelerator-based BNCT System Forecast by Region (2027-2032)
      • 10.1.2 Americas Accelerator-based BNCT System Forecast
      • 10.1.3 APAC Accelerator-based BNCT System Forecast
      • 10.1.4 Europe Accelerator-based BNCT System Forecast
      • 10.1.5 Middle East & Africa Accelerator-based BNCT System Forecast
    • 10.2 Americas Accelerator-based BNCT System Forecast by Country (2027-2032)
      • 10.2.1 United States Market Accelerator-based BNCT System Forecast
      • 10.2.2 Canada Market Accelerator-based BNCT System Forecast
      • 10.2.3 Mexico Market Accelerator-based BNCT System Forecast
      • 10.2.4 Brazil Market Accelerator-based BNCT System Forecast
    • 10.3 APAC Accelerator-based BNCT System Forecast by Region (2027-2032)
      • 10.3.1 China Accelerator-based BNCT System Market Forecast
      • 10.3.2 Japan Market Accelerator-based BNCT System Forecast
      • 10.3.3 Korea Market Accelerator-based BNCT System Forecast
      • 10.3.4 Southeast Asia Market Accelerator-based BNCT System Forecast
      • 10.3.5 India Market Accelerator-based BNCT System Forecast
      • 10.3.6 Australia Market Accelerator-based BNCT System Forecast
    • 10.4 Europe Accelerator-based BNCT System Forecast by Country (2027-2032)
      • 10.4.1 Germany Market Accelerator-based BNCT System Forecast
      • 10.4.2 France Market Accelerator-based BNCT System Forecast
      • 10.4.3 UK Market Accelerator-based BNCT System Forecast
      • 10.4.4 Italy Market Accelerator-based BNCT System Forecast
      • 10.4.5 Russia Market Accelerator-based BNCT System Forecast
    • 10.5 Middle East & Africa Accelerator-based BNCT System Forecast by Region (2027-2032)
      • 10.5.1 Egypt Market Accelerator-based BNCT System Forecast
      • 10.5.2 South Africa Market Accelerator-based BNCT System Forecast
      • 10.5.3 Israel Market Accelerator-based BNCT System Forecast
      • 10.5.4 Turkey Market Accelerator-based BNCT System Forecast
    • 10.6 Global Accelerator-based BNCT System Forecast by Type (2027-2032)
    • 10.7 Global Accelerator-based BNCT System Forecast by Application (2027-2032)
      • 10.7.1 GCC Countries Market Accelerator-based BNCT System Forecast
  • 11 Key Players Analysis

    • 11.1 Neutron Therapeutics
      • 11.1.1 Neutron Therapeutics Company Information
      • 11.1.2 Neutron Therapeutics Accelerator-based BNCT System Product Offered
      • 11.1.3 Neutron Therapeutics Accelerator-based BNCT System Revenue, Gross Margin and Market Share (2021-2026)
      • 11.1.4 Neutron Therapeutics Main Business Overview
      • 11.1.5 Neutron Therapeutics Latest Developments
    • 11.2 Sumitomo Heavy Industries
      • 11.2.1 Sumitomo Heavy Industries Company Information
      • 11.2.2 Sumitomo Heavy Industries Accelerator-based BNCT System Product Offered
      • 11.2.3 Sumitomo Heavy Industries Accelerator-based BNCT System Revenue, Gross Margin and Market Share (2021-2026)
      • 11.2.4 Sumitomo Heavy Industries Main Business Overview
      • 11.2.5 Sumitomo Heavy Industries Latest Developments
    • 11.3 International Particle Therapy Inc (IPT)
      • 11.3.1 International Particle Therapy Inc (IPT) Company Information
      • 11.3.2 International Particle Therapy Inc (IPT) Accelerator-based BNCT System Product Offered
      • 11.3.3 International Particle Therapy Inc (IPT) Accelerator-based BNCT System Revenue, Gross Margin and Market Share (2021-2026)
      • 11.3.4 International Particle Therapy Inc (IPT) Main Business Overview
      • 11.3.5 International Particle Therapy Inc (IPT) Latest Developments
    • 11.4 RaySearch
      • 11.4.1 RaySearch Company Information
      • 11.4.2 RaySearch Accelerator-based BNCT System Product Offered
      • 11.4.3 RaySearch Accelerator-based BNCT System Revenue, Gross Margin and Market Share (2021-2026)
      • 11.4.4 RaySearch Main Business Overview
      • 11.4.5 RaySearch Latest Developments
    • 11.5 Neuboron Medtech
      • 11.5.1 Neuboron Medtech Company Information
      • 11.5.2 Neuboron Medtech Accelerator-based BNCT System Product Offered
      • 11.5.3 Neuboron Medtech Accelerator-based BNCT System Revenue, Gross Margin and Market Share (2021-2026)
      • 11.5.4 Neuboron Medtech Main Business Overview
      • 11.5.5 Neuboron Medtech Latest Developments
    • 11.6 TAE Life Sciences
      • 11.6.1 TAE Life Sciences Company Information
      • 11.6.2 TAE Life Sciences Accelerator-based BNCT System Product Offered
      • 11.6.3 TAE Life Sciences Accelerator-based BNCT System Revenue, Gross Margin and Market Share (2021-2026)
      • 11.6.4 TAE Life Sciences Main Business Overview
      • 11.6.5 TAE Life Sciences Latest Developments
    • 11.7 Stella Pharma
      • 11.7.1 Stella Pharma Company Information
      • 11.7.2 Stella Pharma Accelerator-based BNCT System Product Offered
      • 11.7.3 Stella Pharma Accelerator-based BNCT System Revenue, Gross Margin and Market Share (2021-2026)
      • 11.7.4 Stella Pharma Main Business Overview
      • 11.7.5 Stella Pharma Latest Developments
  • 12 Research Findings and Conclusion

USD 7,320 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.